Implementation of Empagliflozin in Patients with Diabetes Mellitus Type 2 and Established Cardiovascular Disease: Estimation of 5-Year Survival and Costs in Sweden

INTRODUCTION: Cardiovascular disease (CVD) affects approximately 30% of patients with diabetes mellitus type 2 (T2D) and leads to increased morbidity, decreased survival and increased healthcare utilization. The aim of this study was to estimate the impact of treating these patients with the sodium–...

Full description

Saved in:
Bibliographic Details
Published in:Diabetes Ther
Main Authors: Bernfort, Lars, Husberg, Magnus, Wiréhn, Ann-Britt, Rosenqvist, Ulf, Gustavsson, Staffan, Karlsdotter, Kristina, Levin, Lars-Åke
Format: Artigo
Language:Inglês
Published: Springer Healthcare 2020
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7644727/
https://ncbi.nlm.nih.gov/pubmed/33021700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-020-00937-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items